Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. - Wikidata - awgldk - TriplyDB

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

http://www.wikidata.org/entity/Q33833912

about

Interferon-beta for treatment of rheumatoid arthritis?Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature Angiogenesis in the pathogenesis of inflammatory joint and lung diseases αV integrins in angiogenesis and cancer Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist.Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using ⁶⁸Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study A role for angiogenesis in rheumatoid arthritis.Extracellular matrix modulates angiogenesis in physiological and pathological conditions.Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.The role of angiogenesis in rheumatoid arthritis: recent developments Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands.Antagonising angiogenesis in rheumatoid arthritis Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.Sickle red cell-endothelium interactions.Rheumatoid arthritis: developing pharmacological therapies.VEGF and imaging of vessels in rheumatoid arthritis Osteoporosis in the rheumatic disease patient.Antagonizing the αv β3 integrin inhibits angiogenesis and impairs woven but not lamellar bone formation induced by mechanical loading.Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis.Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha Angiogenesis as a target in rheumatoid arthritis.Endothelial FAK as a therapeutic target in disease.Apoptotic cues from the extracellular matrix: regulators of angiogenesis.Regulation of α5 and αV Integrin Expression by GDF-5 and BMP-7 in Chondrocyte Differentiation and Osteoarthritis.Cooperation between VEGF and beta3 integrin during cardiac vascular development.

P2860

Q24793971-528BC6B1-51E5-459E-A834-E1BBD8470803 Q24799893-A243F24B-2EB6-4713-BE03-73CC10DB9227 Q24805418-9F7ACF40-CDFE-4663-A55B-BDB2C1DD55DC Q26851768-80358BB9-BE44-4300-AC6E-019C20D4C2EA Q28576516-073001E2-1DB1-42D1-AE49-59A41F104EBE Q30495730-624AE3E8-628F-41CB-961F-18CEBECE6D1D Q30497615-FF72391A-7838-4235-A930-8BBBCF642347 Q31103443-1C7B7137-D34A-407E-B887-65A1D0C3E333 Q32044975-A3641E06-7866-4D8F-B48E-DC602DA9E00F Q33437895-7E4F7021-7952-4F5C-9A81-2BE30C77BDE5 Q33606824-F94F239B-1DCC-4BA0-A455-C983A8EA4C04 Q33659257-93A2D4FA-D4A3-46DC-A26E-0A1198C1D57F Q33690821-CE037156-016F-47BC-9F9A-39B6A32884A5 Q33737210-E44C184A-3B99-4B4F-AA1B-4177A8540254 Q33762520-858F76F0-0385-452C-AEA7-93C222DFFA3E Q33801264-D130D1A9-F475-410E-B331-E3A79D408C44 Q33939357-7B042614-1213-4524-B9D4-EDA3D88A7F01 Q33964836-BC0BB9D3-1F34-4DE0-85BC-CEFB9D8CE4C9 Q34065809-947A1FB4-DA99-4450-8F91-9063EAD2C91B Q34071300-E0D835B6-D8BF-45D7-B22B-C6F553DA2742 Q34096563-56DE1A09-9D94-4602-A27E-AD3B50B394C3 Q34154425-EF01940B-46A5-44FD-BC4C-5138BEF7B282 Q34528233-167C4856-7B5A-4A07-9FCB-2D504144FDBB Q34560589-70F4041B-CC9D-4670-A2E7-72F6B0B98A89 Q34562028-143AF2F0-F337-4583-9B4D-F0EB1FD7A597 Q34686539-AFB62E9A-6E74-40FC-B093-FA5EFDCCD1B1 Q34706975-C2678F5C-04D9-4C34-8F5F-1F5AFCD3CBE2 Q34731141-81B5E83C-75B9-457D-B7CF-BE629EC93755 Q34986976-57A38339-547B-4983-BB20-9671E7F58BB8 Q35068663-72D2E55B-778C-4A1C-8ABD-CF4DC069260D Q35140465-276E737B-615E-49E0-9826-B5470B92B67B Q35164732-E6B19503-B170-4528-9A03-6249954E0ED3 Q35549474-39FE94A3-304D-4EFE-AD3D-EE8030671DB0 Q35549523-82EF8562-13FE-4A38-BE8B-0547BE2DF529 Q35552325-D09D12D0-7729-4486-8643-82FD4D8CBEA3 Q35553507-1003B76C-BE85-44DF-AC34-DEF0B5C9B9C2 Q35597214-B4F406C3-059C-48A0-99DA-54D33CEE3831 Q35603378-717E1A66-45B5-41C2-BB4B-6A7B746E5D77 Q35641534-B74F5C23-1D44-40C8-8481-CC37090E3B7C Q35642757-85E84F3B-C9D0-4E2D-99BD-57E6DD6FD65D

P2860

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

http://www.wikidata.org/entity/Q33833912

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Decreased angiogenesis and art ...... ith an alphavbeta3 antagonist.

@ast

Decreased angiogenesis and art ...... ith an alphavbeta3 antagonist.

@en

type

label

Decreased angiogenesis and art ...... ith an alphavbeta3 antagonist.

@ast

Decreased angiogenesis and art ...... ith an alphavbeta3 antagonist.

@en

prefLabel

Decreased angiogenesis and art ...... ith an alphavbeta3 antagonist.

@ast

Decreased angiogenesis and art ...... ith an alphavbeta3 antagonist.

@en

P1433

Q33833912-93AB9326-6C20-4E24-B105-4328E06F0630

P1476

Q33833912-AF3B806C-90A5-4528-B09A-03CEC7D5FA16

P2093

Q33833912-041553CF-6E93-4035-A037-B018209E1784

Q33833912-071F8D6E-2E31-4AC8-B1A3-186074C791C5

Q33833912-5C112D23-9E4E-4672-8EF1-36EEF7947B88

Q33833912-A143E7EE-DC74-4276-85F3-9CCDAB536840

Q33833912-B1D87AB0-FEE8-4BE0-9BE2-FB560AD4642A

P2860

Q33833912-04CBF6A7-C5D8-4ABF-A059-60C4FDF332C6

Q33833912-0A0FCB21-4F5D-46F2-921D-5662EE22372A

Q33833912-0FBD7B2E-4596-4D86-B374-0744B370EC4D

Q33833912-2B750C72-4419-42B2-A99D-795EA270F68F

Q33833912-3127784D-DF76-468D-8FCE-7D65494AF6A8

Q33833912-34FDFBC2-A64A-4A8D-8673-845043318A1C

Q33833912-36C5B78E-1E15-4328-860A-A8E6E29B9742

Q33833912-3D9BBE22-524C-4A21-A7CB-2D07C7156BDA

Q33833912-46ED0802-1B35-4D58-8673-0C5AEB0754DB

Q33833912-5BBDB9A0-7005-463C-8B17-B06F5BF05D8B

P304

Q33833912-35D73527-9896-4F6B-B5A7-A707C7568B81

P31

Q33833912-330E5DFD-D12F-432F-B919-8C6F55F14CBB

P356

Q33833912-2C02F492-7240-4A3D-AF37-B0195AF48020

P407

Q33833912-BB0984E8-D95C-4DAC-A604-D0CD030296C2

P433

Q33833912-E7CE5330-3F68-4D62-BFCD-0A72DF657B81

P478

Q33833912-2237894F-7CA1-4934-81A7-440FA352F0BB

P50

Q33833912-AB9BC346-3556-439F-B2D3-312042B9313C

P577

Q33833912-1A6E562A-D5B3-4C52-81AD-CDEAD55C6EF2

P698

Q33833912-67DF5157-E293-4571-A773-535532D2E3AB

P932

Q33833912-189CE927-BBF2-424B-820C-190AA8CE995C

P356

P1433

Journal of Clinical Investigation

P1476

Decreased angiogenesis and art ...... with an alphavbeta3 antagonist

@en

P2093

A Jonczyk

http://www.w3.org/2001/XMLSchema#string

C M Storgard

http://www.w3.org/2001/XMLSchema#string

D A Cheresh

http://www.w3.org/2001/XMLSchema#string

D G Stupack

http://www.w3.org/2001/XMLSchema#string

R I Fox

http://www.w3.org/2001/XMLSchema#string

P2860

Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Requirement of vascular integrin alpha v beta 3 for angiogenesis

Expression of basic fibroblast growth factor in synovial tissues from patients with rheumatoid arthritis: detection by immunohistological staining and in situ hybridisation

Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies.

Inhibition of human endothelial cell proliferation by gold compounds.

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

Focally regulated endothelial proliferation and cell death in human synovium.

Transient functional expression of alphaVbeta 3 on vascular cells during wound repair

P304

47-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI3756

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Simon L Goodman

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9884333

http://www.w3.org/2001/XMLSchema#string

P932

407856

http://www.w3.org/2001/XMLSchema#string